Pharmaceutical - Anti-virals


Current filters:


Popular Filters

301 to 323 of 323 results

Scientists report new approach to attack flu virus


An international research team has manufactured a new protein that can combat deadly flu epidemics. The…


Tanzanian drugmaker to start producing ARVs in August


Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

US House of Representatives trumps Administration on Global AIDS budgets


The US House of Representatives has budgeted $193 million more to global AIDS programs in the 2013 Foreign…

Anti-viralsFinancialHealthcareNorth AmericaPharmaceuticalPolitics

All "baby boomers" should be tested once for hepatitis C, says USA's CDC


On the eve of the first ever National Hepatitis Testing Day (May 19), the US Centers for Disease Control…

Anti-viralsHealthcareNorth AmericaPharmaceuticalRegulation

US FDA fast-tracks Achillion's hepatitis C drug candidate


USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) says it has received Fast Track designation from the…

Achillion PharmaceuticalsAnti-viralsNorth AmericaPharmaceuticalRegulation

FDA advisory thumbs up for Gilead's once-daily Quad for HIV


There was more good news for Gilead Sciences (Nasdaq: GILD), the world's largest maker of HIV drugs,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalQuadRegulation

Novartis makes Tekturna label change, updates on Gilenya and stops alisporivir trial


In a day of mixed news for the Swiss drug major, Novartis (NOVN: VX) said yesterday that it has updated…


Bristol-Myers expands hepatitis C accord with Medivir and Janssen


Swedish infectious disease drug developer Medivir AB (OMX: MVIR) said yesterday that its development…

Anti-viralsBristol-Myers SquibbdaclatasvirJanssenJohnson & JohnsonLicensingMedivirPharmaceuticalResearch

Incivek versus Victrelis in hepatitis C virus treatment: US physician views


For the treatment of hepatitis C virus (HCV), the majority of surveyed US physicians survey by advisory…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

ViiV and Shionogi say dolutegravir meets primary endpoint in HIV


ViiV Healthcare, the HIV/AIDS joint venture of UK drugs giant GlaxoSmithKline (LSE: GSK) and US behemoth…

Anti-viralsdolutegravirGlaxoSmithKlinePfizerPharmaceuticalResearchShionogiViiV Healthcare

Positive NICE news for Gilenya for MS and Incivo for hep C


There was good news from the UK drugs watchdog the Institute for Health and Clinical Excellence (NICE)…

Anti-viralsEuropeGilenyaIncivoJanssen-CilagJohnson & JohnsonNeurologicalNovartisPharmaceuticalPricingRegulation

Alkermes pulls MAA for Megestrol product


The European Medicines Agency says it has been formally notified by the Irish subsidiary of US drugmaker…


NICE backs Merck & Co hep C drug Victrelis


UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) has today (March 9)…

Anti-viralsEuropeMerck & CoPharmaceuticalPricingRegulationVictrelis

EU Commission OKs Baxter Avian flu vaccine Vepacel; drops GSK probe


US drugmaker Baxter International (NYSE:BAX) says that the European Commission has granted marketing…

Anti-viralsBaxter InternationalEuropeGlaxoSmithKlineLegalPharmaceuticalRegulationSynthonVaccinesVepacel

FDA OKs first quadrivalent flu vaccine; and lower dose Angeliq


Anglo-Swedish drug major AstraZeneca (LSE: AZN) US unit MedImmune's FluMist Quadrivalent, a vaccine to…

Anti-viralsNorth AmericaPharmaceuticalRegulationVaccinesWomen's Health

Enanta Pharma in $440 HCV licensing deal with Novartis


USA-based discovery and development company Enanta Pharmaceuticals yesterday signed an exclusive collaboration…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

EMA recommends new Rxing info on Victrelis and warnings for aliskiren


The European Medicines Agency has recommended updating the prescribing information for US drug giant…

Aliskiren TabletsAnti-viralsCardio-vascularEuropeMerck & CoNovartisPharmaceuticalRasilezRegulationTekturnaVictrelis

US FDA priority review for Truvada for reducing HIV risk


The US Food and Drug Administration has accepted the supplemental New Drug Application and granted a…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

301 to 323 of 323 results

Back to top